Dianthus Therapeutics, Inc. (DNTH) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -28.86M | -46.98M | -30.55M | -23.89M | -27.63M | -27.44M | -21.27M | -14.53M | -14.94M | -11.85M | 1.5M | -4.73M |
| Operating CF Margin % | -6232.4% | -16543.31% | -7715.91% | -12379.27% | -2375.75% | -2069.68% | -979.14% | -779.82% | -1709.5% | -2593.87% | 162.01% | -488.24% |
| Operating CF Growth % | -4.44% | -71.2% | -43.67% | -64.45% | -84.93% | -131.52% | -1520.64% | -207.08% | -45.28% | -33.93% | -90.86% | 71.93% |
| Net Income | -40.83M | -64.43M | -36.77M | -31.63M | -29.51M | -28.44M | -25.17M | -17.61M | -13.75M | -10.56M | -14.76M | -11.14M |
| Depreciation & Amortization | 76K | 97K | 99K | 99K | 133K | 78K | 116K | 111K | 107K | 103K | 19K | 84K |
| Stock-Based Compensation | 10.6M | 5.98M | 5.79M | 5.71M | 5.32M | 3.92M | 3.84M | 3.1M | 2.04M | 726K | 1.18M | 462K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -916K | -1.11M | -2.54M | -1.12M | -1.9M | -2.58M | -2.65M | -422K | -518K | -527K | 4.68M | -208K |
| Working Capital Changes | 2.22M | 12.48M | 2.85M | 3.05M | -1.66M | -422K | 2.6M | 289K | -2.82M | -1.59M | 10.38M | 6.07M |
| Change in Receivables | -1.18M | 4.95M | -4.96M | 961K | -193K | 1.88M | -1.01M | -799K | -398K | 273K | 0 | 3.69M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 7M | 6.68M | 3M | 3.09M | -1.5M | 2.28M | 5.65M | 3.25M | -2.99M | 1.6M | 484K | 3.01M |
| Cash from Investing | -133.97M | 37.2M | -201.28M | 26.45M | 14.79M | -23.11M | -259.36M | 1.17M | -5.51M | -8.24M | -16.88M | 21.86M |
| Capital Expenditures | -10K | -138K | -5K | -46K | -24K | -31K | -25K | -17K | -32K | -10K | 145K | -21K |
| CapEx % of Revenue | 2.16% | 48.59% | 1.26% | 23.83% | 2.06% | 2.34% | 1.15% | 0.91% | 3.66% | 2.19% | 15.69% | 2.17% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.38M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 739.41M | 4.88M | 274.51M | 568K | 161K | 39.68M | 296K | -2.2M | 217.85M | -4.87M | 154.08M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.64M | 0 |
| Equity Issued (Net) | 739.41M | -275.24M | 274.51M | 568K | 161K | 39.2M | 296K | 215.38M | 230M | 0 | 72M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 317K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 280.13M | 0 | 0 | 0 | 476K | 0 | -217.58M | -12.15M | -4.87M | 66.44M | 0 |
| Net Change in Cash | 576.58M | -4.9M | 42.68M | 3.12M | -12.68M | -10.88M | -280.5M | -15.55M | 197.4M | -24.96M | 94.65M | 17.13M |
| Free Cash Flow | -28.87M | -47.12M | -30.56M | -23.94M | -27.65M | -27.48M | -21.29M | -14.54M | -14.97M | -11.86M | 1.64M | -4.75M |
| FCF Margin % | -6234.56% | -16591.9% | -7717.17% | -12403.11% | -2377.82% | -2072.02% | -980.29% | -780.73% | -1713.16% | -2596.06% | 177.71% | -490.4% |
| FCF Growth % | -4.38% | -71.5% | -43.53% | -64.58% | -84.69% | -131.58% | -1396.71% | -206.08% | -45.4% | -33.6% | -90% | 72.02% |
| FCF per Share | -0.60 | -1.25 | -0.81 | -0.67 | -0.77 | -0.78 | -0.62 | -0.42 | -0.58 | -2.62 | 0.42 | -1.25 |
| FCF Conversion (FCF/Net Income) | 0.71x | -0.48x | 0.83x | 0.76x | 0.94x | 0.96x | 0.84x | 0.83x | 1.09x | 1.12x | -0.10x | 0.42x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |